| Product Code: ETC9692148 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Pharma 4.0 Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Pharma 4.0 Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Pharma 4.0 Market - Industry Life Cycle |
3.4 Thailand Pharma 4.0 Market - Porter's Five Forces |
3.5 Thailand Pharma 4.0 Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Thailand Pharma 4.0 Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Thailand Pharma 4.0 Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Thailand Pharma 4.0 Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of digital technologies in the pharmaceutical industry |
4.2.2 Government initiatives to promote digital transformation in healthcare |
4.2.3 Growing demand for personalized medicine and precision healthcare |
4.3 Market Restraints |
4.3.1 Data privacy and security concerns |
4.3.2 Resistance to change and traditional mindset within the industry |
5 Thailand Pharma 4.0 Market Trends |
6 Thailand Pharma 4.0 Market, By Types |
6.1 Thailand Pharma 4.0 Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Thailand Pharma 4.0 Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Thailand Pharma 4.0 Market Revenues & Volume, By Artificial Intelligence (AI), 2021- 2031F |
6.1.4 Thailand Pharma 4.0 Market Revenues & Volume, By Big Data Analytics, 2021- 2031F |
6.1.5 Thailand Pharma 4.0 Market Revenues & Volume, By Cloud Computing, 2021- 2031F |
6.1.6 Thailand Pharma 4.0 Market Revenues & Volume, By Internet of Things (IoT), 2021- 2031F |
6.1.7 Thailand Pharma 4.0 Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Pharma 4.0 Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand Pharma 4.0 Market Revenues & Volume, By Drug Discovery and Development, 2021- 2031F |
6.2.3 Thailand Pharma 4.0 Market Revenues & Volume, By Clinical Trials, 2021- 2031F |
6.2.4 Thailand Pharma 4.0 Market Revenues & Volume, By Manufacturing, 2021- 2031F |
6.2.5 Thailand Pharma 4.0 Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Pharma 4.0 Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Thailand Pharma 4.0 Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.3.3 Thailand Pharma 4.0 Market Revenues & Volume, By Biotechnology Companies, 2021- 2031F |
6.3.4 Thailand Pharma 4.0 Market Revenues & Volume, By CROs and CMOs, 2021- 2031F |
6.3.5 Thailand Pharma 4.0 Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Pharma 4.0 Market Import-Export Trade Statistics |
7.1 Thailand Pharma 4.0 Market Export to Major Countries |
7.2 Thailand Pharma 4.0 Market Imports from Major Countries |
8 Thailand Pharma 4.0 Market Key Performance Indicators |
8.1 Percentage increase in the adoption of digital health solutions by pharmaceutical companies in Thailand |
8.2 Number of government policies and incentives supporting digital transformation in the healthcare sector |
8.3 Growth in investments in research and development of personalized medicine in Thailand |
9 Thailand Pharma 4.0 Market - Opportunity Assessment |
9.1 Thailand Pharma 4.0 Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Thailand Pharma 4.0 Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Thailand Pharma 4.0 Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Thailand Pharma 4.0 Market - Competitive Landscape |
10.1 Thailand Pharma 4.0 Market Revenue Share, By Companies, 2024 |
10.2 Thailand Pharma 4.0 Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here